SCHEMBL6773103

SCHEMBL6773103

Cc1cc(O)c2c3c(C(N)=O)cccc3n(Cc3cccc(Cc4ccccc4)c3)c2c1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 13/20 0.44
PLA2G10 O15496 4/20 0.39
PLA2G1B P04054 3/20 0.39
PLA2G5 P39877 2/20 0.39
PLA2G2E Q9NZK7 2/20 0.39
KLK1 P06870 1/20 0.39
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NOTUM Q6P988 1/20 0.37
IDH1 O75874 1/20 0.36
F10 P00742 1/20 0.36
HNF4A P41235 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6690357 0.92 PLA2G2A (0.51) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6776997 0.90 PLA2G2A (0.48) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6691732 0.89 ADRA1D (0.44) PLA2G2AMEN1KMT2AF10
SCHEMBL6775943 0.89 PLA2G2A (0.49) PLA2G2APLA2G10KLK1MEN1KMT2A
SCHEMBL6775713 0.89 PLA2G2A (0.43) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6777282 0.89 PLA2G2A (0.41) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6774933 0.88 PLA2G2A (0.42) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6894729 0.88 MAPT (0.41) PLA2G2ATP53NPSR1F10
SCHEMBL6774350 0.87 PLA2G2A (0.40) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E
SCHEMBL6776978 0.87 PLA2G2A (0.42) PLA2G2APLA2G10PLA2G1BPLA2G5PLA2G2E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713645-B1 INHIBITING SPLA2 MEDIATED RELEASE OF FATTY ACIDS FOR TREATMENT OF CONDITIONS SUCH AS SEPTIC SHOCK ELI LILLY AND COMPANY 2004-03-30 US disclosed
US-6177440-B1 THERAPY FOR SEPSIS SHOCK; PHOSPHOLIPASE INHBITOR ELI LILLY AND COMPANY 2001-01-23 US disclosed
EP-0952149-A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitiors ELI LILLY AND COMPANY (US) 1999-10-27 EP disclosed